Artwork

Dexcom에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Dexcom 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

CGM Accuracy with John Pemberton RD, specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital

12:02
 
공유
 

Manage episode 448431579 series 3605397
Dexcom에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Dexcom 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

What is MARD as a measure for CGM accuracy? What does it mean and how is it calculated? John Pemberton discusses how to look at accuracy studies across different CGM devices and the differences between CE mark approvals in the UK and USA/Australia. An enlightening listen around something you may see everyday as a healthcare professional but would like to know more about. Link to the study discussed is in the show notes.
With / speaker;
John Pemberton RD specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital
Refs for description
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
John S Pemberton et al, CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes Obes Metab. 2023; 25(4):916-939.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom ONE+, Dexcom Share, Share are trademark or registered trademarks in the U.S. and may be in other countries. © 2024 Dexcom, Inc. All rights reserved. Dexcom International, Ltd. and its affiliated European entities. 1 Tanfield, Suite 6, Level 1 Tanfield, Edinburgh EH3 5DA.
Further CPD accredited education can be found on the Dexcom Education Hub

  continue reading

9 에피소드

Artwork
icon공유
 
Manage episode 448431579 series 3605397
Dexcom에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Dexcom 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

What is MARD as a measure for CGM accuracy? What does it mean and how is it calculated? John Pemberton discusses how to look at accuracy studies across different CGM devices and the differences between CE mark approvals in the UK and USA/Australia. An enlightening listen around something you may see everyday as a healthcare professional but would like to know more about. Link to the study discussed is in the show notes.
With / speaker;
John Pemberton RD specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital
Refs for description
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
John S Pemberton et al, CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes Obes Metab. 2023; 25(4):916-939.

This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.

All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom ONE+, Dexcom Share, Share are trademark or registered trademarks in the U.S. and may be in other countries. © 2024 Dexcom, Inc. All rights reserved. Dexcom International, Ltd. and its affiliated European entities. 1 Tanfield, Suite 6, Level 1 Tanfield, Edinburgh EH3 5DA.
Further CPD accredited education can be found on the Dexcom Education Hub

  continue reading

9 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드

탐색하는 동안 이 프로그램을 들어보세요.
재생